AAAAAA

   
Results: 1-12 |
Results: 12
Acents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer
Authors: Kelloff, GJ Lieberman, R Seele, VE Boone, CM Lubet, RA Kopelovich, L Malone, WA Crowell, JA Higley, HR Sigman, CC
Citation: Gj. Kelloff et al., Acents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer, UROLOGY, 57(4A), 2001, pp. 46-51
Potential use of lipoxygenase inhibitors for cancer chemoprevention
Authors: Steele, VE Holmes, CA Hawk, ET Kopelovich, L Lubet, RA Crowell, JA Sigman, CC Kelloff, GJ
Citation: Ve. Steele et al., Potential use of lipoxygenase inhibitors for cancer chemoprevention, EXPERT OP I, 9(9), 2000, pp. 2121-2138
Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer
Authors: Kelloff, GJ Sigman, CC Johnson, KM Boone, CW Greenwald, P Crowell, JA Hawk, ET Doody, LA
Citation: Gj. Kelloff et al., Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer, CANC EPID B, 9(2), 2000, pp. 127-137
Clinical development of estrogen modulators for breast cancer chemoprevention in premenopausal vs. postmenopausal women
Authors: Lawrence, JA Malpas, PB Sigman, CC Kelloff, GJ
Citation: Ja. Lawrence et al., Clinical development of estrogen modulators for breast cancer chemoprevention in premenopausal vs. postmenopausal women, J CELL BIOC, 2000, pp. 103-114
Retinoids in chemoprevention and differentiation therapy
Authors: Hansen, LA Sigman, CC Andreola, F Ross, SA Kelloff, GJ De Luca, LM
Citation: La. Hansen et al., Retinoids in chemoprevention and differentiation therapy, CARCINOGENE, 21(7), 2000, pp. 1271-1279
Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays
Authors: Steele, VE Kelloff, GJ Balentine, D Boone, CW Mehta, R Bagheri, D Sigman, CC Zhu, SY Sharma, S
Citation: Ve. Steele et al., Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays, CARCINOGENE, 21(1), 2000, pp. 63-67
Progress in cancer chemoprevention: Development of diet-derived chemopreventive agents
Authors: Kelloff, GJ Crowell, JA Steele, VE Lubet, RA Malone, WA Boone, CW Kopelovich, L Hawk, ET Lieberman, R Lawrence, JA Ali, I Viner, JL Sigman, CC
Citation: Gj. Kelloff et al., Progress in cancer chemoprevention: Development of diet-derived chemopreventive agents, J NUTR, 130(2), 2000, pp. 467S-471S
Lipoxygenase inhibitors as potential cancer chemopreventives
Authors: Steele, VE Holmes, CA Hawk, ET Kopelovich, L Lubet, RA Crowell, JA Sigman, CC Kelloff, GJ
Citation: Ve. Steele et al., Lipoxygenase inhibitors as potential cancer chemopreventives, CANC EPID B, 8(5), 1999, pp. 467-483
Cancer chemoprevention: Progress and promise (Reprinted from Eur J Cancer,vol 35, pg 1755-1762, 1999)
Authors: Kelloff, GJ Sigman, CC Greenwald, P
Citation: Gj. Kelloff et al., Cancer chemoprevention: Progress and promise (Reprinted from Eur J Cancer,vol 35, pg 1755-1762, 1999), EUR J CANC, 35(14), 1999, pp. 2031-2038
Cancer chemoprevention: Progress and promise
Authors: Kelloff, GJ Sigman, CC Greenwald, P
Citation: Gj. Kelloff et al., Cancer chemoprevention: Progress and promise, EUR J CANC, 35(13), 1999, pp. 1755-1762
Chemoprevention of prostate cancer: Concepts and strategies
Authors: Kelloff, GJ Lieberman, R Steele, VE Boone, CW Lubet, RA Kopelovitch, L Malone, WA Crowell, JA Sigman, CC
Citation: Gj. Kelloff et al., Chemoprevention of prostate cancer: Concepts and strategies, EUR UROL, 35(5-6), 1999, pp. 342-350
Preclinical efficacy studies of green and black tea extracts
Authors: Steele, VE Bagheri, D Balentine, DA Boone, CW Mehta, R Morse, MA Sharma, S Sigman, CC Stoner, GD Wargovich, MJ Weisburger, JH Zhu, SY Kelloff, GJ
Citation: Ve. Steele et al., Preclinical efficacy studies of green and black tea extracts, P SOC EXP M, 220(4), 1999, pp. 210-212
Risultati: 1-12 |